Tag Archives: Schering Plough

Merck to Close Eight Plants

By Oriana Schwindt | Published: July 8, 2010
Image by Getty Images via @daylife Over the next two years, Merck will shut down eight manufacturing plants, as well as eight research sites, as part of the ongoing Schering-Plough merger process. The company said in a statement that the various site exits will help “create a flexible R&D organization.” Taking a page out of Pfizer’s book [...]
Posted in Strategy | Also tagged , , , , , , | 3 Comments

Merck Shows Off Bevy of New Drugs

By George Koroneos | Published: May 6, 2010
Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for launch within [...]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment

A Few Words About Diversification

By Julian Upton | Published: February 1, 2010
Guest blog by Dr Brian White, an analyst at Shore Capital. As a result of the feared impact of the patent expiry cliff, the decimation of branded sales by multi-sourced generics and the obstacles erected, especially by managed care in the US, to slow the uptake of branded pharmaceuticals where a generic in the same class [...]
Posted in Europe, Global, Guest Blog, Strategy | Also tagged , , , , , | Leave a comment

Cold Cuts: Merck Layoffs Loom

By Reid Paul | Published: January 7, 2010
Image via Wikipedia It is not just cold outside these days, as Merck & Co. makes some cold hard decisions. Following on the heels of its now closed acquisition of Schering-Plough, Merck is making significant job cuts across its operations. Some 16,000 jobs are expected to be eliminated in total as a result of the merger. According [...]
Posted in Strategy | Also tagged , , , | Leave a comment

Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger

By Andrew Sheivachman | Published: November 5, 2009
Image via Wikipedia After Merck & Co. officially announced its $41.1 billion merger with Schering-Plough yesterday, CEO Richard Clark made it clear his company is still looking to expand through further acquisitions and mergers. According to the Wall Street Journal’s Health Blog: Clark told us today that the newly combined company  is “actively looking” for biotechs to [...]
Posted in Strategy | Also tagged , , , , , , | 2 Comments